Clinical Trial

Investigating Ovulation Inhibition for Use as a Contraceptive

Name: Investigating Ovulation Inhibition for Use as a Contraceptive — clinical trial record (NCT07365904)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR 130A 01 contraceptive transdermal patch

Trial Details

NCT Number	NCT07365904
Lead Sponsor	Mylan Pharmaceuticals Inc
Conditions	Contraception
Enrollment	60 participants
Start Date	2025-12-22
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-26